The results showed that all seven tested tumors were positive for high levels of nuclear NF-κB/p65RelA, a key molecule that mediates the transcription of inflammatory cytokines, as previously reported in HER2+ breast tumors [24]. This evidence concerns the gene ERBB2 and breast neoplasm.